skip banner navigation
National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Clinical Trials Search Results
Quick Links
Dictionary

Funding Opportunities

NCI Publications

NCI Calendar

Español
NCI Highlights
Chemo Extends Life in Advanced Prostate Cancer

Temozolomide Plus Radiation Helps Brain Cancer

Confirmed: Raloxifene Drops Risk of Breast Cancer

Bortezomib Delays Progression of Multiple Myeloma

Annual Report to the Nation

Past Highlights
Need Help?
Results: 1-10 of 229   Show     results per page
View Search Criteria | Help With Results
Sort By:    Version:    Format:   
Last Modified: 6/1/2002     First Published: 1/1/1996  

1.

Phase III Randomized Study of Vaginal Hysterectomy and Bilateral Salpingo-Oophorectomy (BSO) Via Laparoscopy Versus Total Abdominal Hysterectomy and BSO Via Conventional Laparotomy Plus Pelvic and Para-Aortic Lymph Node Sampling in Patients With Stage I or IIA, Grade I-III Endometrial Cancer or Uterine Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Active


18 and over


NCI


GOG-LAP2


Last Modified: 6/8/2004     First Published: 8/1/1998  

2.

Phase III Study of Intraoperative Lymphatic Mapping in Patients With Invasive Squamous Cell Carcinoma of the Vulva
Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Diagnostic, Treatment


Active


Any age


NCI


GOG-173


Last Modified: 7/9/2004     First Published: 2/1/1999  

3.

Phase III Randomized Study of Methotrexate Versus Dactinomycin in Patients With Low-Risk Gestational Trophoblastic Neoplasia
Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Active


Not specified


NCI


GOG-174
ECOG-G174

Last Modified: 6/3/2004     First Published: 4/1/2000  

4.

Phase III Randomized Study of Oral Thalidomide Versus Placebo in Patients With Androgen-Dependent Nonmetastatic Prostate Cancer After Limited Hormonal Ablation
Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Active


18 and over


NCI


NCI-00-C-0080
NCI-T99-0053

Last Modified: 3/26/2003     First Published: 5/1/2000  

5.

Phase III Pilot Randomized Study of Filgrastim-SD/01 Versus Filgrastim (G-CSF) With Concurrent Chemotherapy in Patients With Newly Diagnosed Sarcoma
Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Supportive care, Treatment


Active


25 and under at diagnosis


NCI


NCI-00-C-0092F
AMGEN-20000124

Last Modified: 6/8/2004     First Published: 1/1/2002  

6.

Phase III Randomized Study of Fibrin Sealant to Reduce Lymphedema Incidence After Lymph Node Dissection in Patients With Vulvar Malignancies
Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Supportive care


Active


Over 18


NCI


GOG-0195
NCI-P01-0201

Last Modified: 6/7/2004     First Published: 7/1/2002  

7.

Phase III Randomized Study of Tamoxifen Versus Thalidomide in Patients With Only a Biochemical Recurrence of Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer After First-Line Chemotherapy
Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Active


Not specified


NCI


GOG-0198


Last Modified: 4/7/2004     First Published: 2/21/2003  

8.

Phase III Randomized Study of Operative Debulking and Systemic Chemotherapy With or Without Intra- and Peri-Operative Intraperitoneal Chemotherapy in Patients With Peritoneal Carcinomatosis From Low-Grade Gastrointestinal Adenocarcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Active


18 and over


NCI


NCI-03-C-0085


Last Modified: 6/8/2004     First Published: 3/24/2003  

9.

Phase III Randomized Study of Amifostine Versus No Treatment For Platinum-Induced Peripheral Neuropathy in Patients With Gynecologic Malignancies
Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Supportive care


Active


18 and over


NCI


GOG-0192


Last Modified: 6/8/2004     First Published: 6/23/2003  

10.

Phase III Randomized Study of Paclitaxel and Cisplatin Versus Vinorelbine and Cisplatin Versus Gemcitabine and Cisplatin Versus Topotecan and Cisplatin in Patients With Stage IVB, Recurrent, or Persistent Carcinoma of the Cervix
Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Active


18 and over


NCI


GOG-0204


   Select All on One Page
Refine Search   Display for Print   New Search 1 2 3 4   Next >
skip footer navigation

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health FirstGov.gov